Skip to main content
SpringerLink
Log in

Single-Composition Extended-Release Metformin Hydrochloride

A Viewpoint by Vivian Fonseca

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Treatments in Endocrinology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–65

    Article  Google Scholar 

  2. Dandona P, Fonseca V, Mier A, et al. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6: 472–4

    Article  PubMed  CAS  Google Scholar 

  3. Fonseca V, Desouza C, Asnani S, et al. Nontraditional risk factors for cardiovascular disease in diabetes. Endocr Rev 2004; 25: 153–75

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tulane University Health Sciences Center, New Orleans, Louisiana, USA

    Vivian Fonseca

Authors
  1. Vivian Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fonseca, V. Single-Composition Extended-Release Metformin Hydrochloride. Mol Diag Ther 3, 333–334 (2004). https://doi.org/10.2165/00024677-200403050-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024677-200403050-00010

Search

Navigation